investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leukemia
Harlan S. Robins
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Harlan S. Robins
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Derek B. Sant'Angelo
Control of cytokine production by human NK cells
Leukaemia
Gerd P Pfeifer
5-hydroxymethylcytosine in Human Cancer
Leukaemia
Jon C Aster
Oncogenic Notch Signaling
Leukaemia
Pathology
Hematology and hematologic malignancies
Scott E Evans
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
Leukaemia
Omar Abdel-Wahab
Role of ASXL1 mutations in myeloid malignancies
Leukaemia
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Leukaemia
Robert Stanley
Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms
Leukaemia
Hematology and hematologic malignancies
Scott A Armstrong
Targeting to Epigenetic Modications in ALL
Leukaemia
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies